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Abstract
Lactoferricin B (LfcinB) is a well-known antimicrobial peptide. Several studies have indicated that it can inhibit bacteria by
affecting intracellular activities, but the intracellular targets of this antimicrobial peptide have not been identified. Therefore,
we used E. coli proteome chips to identify the intracellular target proteins of LfcinB in a high-throughput manner. We
probed LfcinB with E. coli proteome chips and further conducted normalization and Gene Ontology (GO) analyses. The
results of the GO analyses showed that the identified proteins were associated with metabolic processes. Moreover, we
validated the interactions between LfcinB and chip assay-identified proteins with fluorescence polarization (FP) assays.
Sixteen proteins were identified, and an E. coli interaction database (EcID) analysis revealed that the majority of the proteins
that interact with these 16 proteins affected the tricarboxylic acid (TCA) cycle. Knockout assays were conducted to further
validate the FP assay results. These results showed that phosphoenolpyruvate carboxylase was a target of LfcinB, indicating
that one of its mechanisms of action may be associated with pyruvate metabolism. Thus, we used pyruvate assays to
conduct an in vivo validation of the relationship between LfcinB and pyruvate level in E. coli. These results showed that E.
coli exposed to LfcinB had abnormal pyruvate amounts, indicating that LfcinB caused an accumulation of pyruvate. In
conclusion, this study successfully revealed the intracellular targets of LfcinB using an E. coli proteome chip approach.
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Introduction
The human immune system is divided into innate and adaptive
systems. The innate immune system defends the host from
infections in a non-specific fashion. This system exists in all
animals and plants and is the first line of defense against invading
organisms. One of the most important elements of the innate
immune system is the antimicrobial peptide.
Natural antimicrobial peptides are pervasive in plants, insects
and animals. They have been demonstrated to kill or inhibit the
growth of bacteria, fungi, cancer cells and viruses [1–3]. LfcinB is
a cationic antimicrobial peptide consisting of 25 amino acids that
has been found to be present in many mammals for innate
immunity. Similar to other cationic antimicrobial peptides [4],
LfcinB exerts its antimicrobial activities via a pore-forming
mechanism [5]. LfcinB also inhibits bacterial growth by impeding
intracellular activities without destroying membrane integrity or
penetrating the cytoplasmic membrane [6]. Ulvatne et al. [7]
further observed that LfcinB at a sublethal concentration inhibited
DNA, RNA and protein synthesis of E. coli and induced
filamentation during an SOS-response in bacteria. These results
suggest that LfcinB has multiple intracellular targets in bacteria.
Although several reports have observed that LfcinB inhibited
intracellular activities in bacteria, the intracellular targets of LfcinB
are still unknown. Thus, a high-throughput platform is needed to
globally identify the interactions between LfcinB and the entire
proteome. A proteome chip, also known as a proteome
microarray, contains most of the individually purified proteins in
a given proteome and is one potential platform that allows high-
throughput identification of protein interactions in a single
experiment [8,9]. Proteome chips have been used to discover
protein-DNA, protein-lipid, protein-drug and protein-peptide
interactions [10,11], and have become a powerful technology for
systems biology [12]. In addition, proteome chip assays, which can
be completed in hours, are faster and simpler than other
proteomic tools [13]. Several proteome chips have been
fabricated, including yeast, E. coli and human [8,9,14]. Chen
et al. [9] developed a high-throughput protein expression and
purification protocol to fabricate an E. coli proteome chip and
applied it to the discovery of DNA damage-recognition activities.
Moreover, E. coli proteome chips were used to identify serological
biomarkers for inflammatory bowel disease [15] and screened for
the substrates of the protein acetyltransferase [16]. These results
demonstrated that the E. coli proteome chip is a powerful tool to
globally identify the interacting proteins of certain molecules.
Herein, we utilized the E. coli proteome chip to identify the
intracellular targets of LfcinB. The overall scheme for this
identification method is shown in Figure 1. A novel feature of
this methodology is the use of a high-throughput platform to begin
this study and GO was used to analyze the targets of LfcinB. The
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were not only analyzed by the EcID but also further validated by
knockout assays. The results showed that one of the mechanisms of
LfcinB action was highly related to pyruvate metabolism. Finally,
we conducted pyruvate assays to confirm the influence of LfcinB
on pyruvate levels in E. coli.
Results
E. coli proteome chip assays
In this study, we incubated LfcinB with E. coli proteome chips to
identify LfcinB-binding proteins. To provide the signal for LfcinB
in E. coli proteome chip assays, LfcinB was labeled with biotin. To
confirm that the biotinylated LfcinB used in the chip assays has the
same antimicrobial activity as unbiotinylated LfcinB, biotinylated
LfcinB, LfcinB and biotin were tested separately for their E. coli
inhibition ability. As shown in Figure 2, LfcinB and biotinylated
LfcinB showed similar growth curves and exhibited the same
inhibition of E. coli growth; however, the growth curve of E. coli
with biotin was similar to that of E. coli with phosphate-buffered
saline (PBS). These results suggest that biotin-labeled LfcinB
retains the antimicrobial activity of LfcinB. Moreover, free biotin
had no influence on E. coli growth.
In the chip assays, biotinylated LfcinB was first probed with E.
coli proteome chips. DyLight
TM 649-labeled streptavidin and
DyLight
TM 549-labeled anti-His antibodies were then probed with
the chips (Figure 3A). The anti-His antibody was used to detect the
printed proteins tagged with histidine to represent the relative
amount of proteins on the chips, and the majority of the proteins
showed strong signals (Figure S1). Because of the strong affinity
between biotin and streptavidin, fluorescently labeled streptavidin
was used to label LfcinB. The image of proteome chips probed
with biotinylated LfcinB in triplicate assays are shown in Figure 3B,
and the same enlarged regions from three different chip assays
show high reproducibility. ProCAT [17] was used for signal
normalization and helped us determine positive hits by the
principle of local cut-off, based on the ratio of DyLight
TM 649 to
DyLight
TM 549. By ruling out membrane proteins from the top
5% of the E. coli entire proteome, we selected 153 proteins for
further analysis (Table 1).
To globally classify and analyze the identified proteins in chip
assays, we assigned them based on function in GO [18], and the
Cytoscape plug-in BiNGO [19] was used to statistically determine
enriched proteins of the GO categories in a biological network.
From these data, 115 out of 153 candidate proteins in the chip
assays were annotated to at least one GO term. As shown in
Figure 4, the identified proteins were enriched in the following
biological processes: cellular macromolecular metabolic processes,
macromolecular metabolic processes, primary metabolic process-
es, cellular macromolecule biosynthetic processes and macromol-
ecule biosynthetic processes (p,10
24). These results may explain
an earlier finding that LfcinB inhibited bacterial macromolecular
biosynthesis [7]. Moreover, more identified proteins were
annotated to metabolic processes but fewer to biological
regulations. This differentiation suggests that the targets of LfcinB
may be highly involved in the general metabolic pathway, but not
as regulators. For molecular function (Figure 4B), most of the
identified proteins were associated with the term ‘‘binding’’, in
particular ‘‘protein binding’’ (p,10
24). However, the greatest
enrichment was observed in biological processes, not in molecular
functions. Specifically, the identified proteins are enriched in
downstream metabolic processes.
Fluorescence polarization assays
FP assays, investigations of the binding between two molecules
in a homogeneous aqueous environment, were used to validate the
identified 153 proteins. These assays have been used to measure
various molecular interactions, including protein-protein, protein-
peptide and ligand-receptor interactions [20–23]. If a fluorophore
only binds to a small molecule, such as peptide, the rotation of the
complex is fast and the light emits in a different plane of
polarization. Therefore, the degree of polarization is low.
Figure 1. Scheme for the identification of intracellular targets
of LfcinB. We used a high-throughput protein purification protocol to
purify ,4,300 E. coli proteins. These proteins were printed onto
Fullmoon slides to fabricate E. coli proteome chips. We then probed
LfcinB with E. coli proteome chips and analyzed the chip assay results
by bioinformatics analyses. FP assays were then used to validate the
identified proteins and 16 proteins were confirmed to be bound to
LfcinB. We conducted knockout assays to further validate the 16
proteins and the EcID was used to observe the functional interactions of
these 16 proteins. The knockout assay results revealed that one of the
mechanisms of LfcinB action was associated with pyruvate metabolism.
Finally, we used pyruvate assays to observe the relationship between
LfcinB and pyruvate.
doi:10.1371/journal.pone.0028197.g001
Figure 2. The antibacterial activities of biotinylated LfcinB,
LfcinB and biotin. To confirm whether biotinylated LfcinB has
different antibacterial activity than unbiotinylated LfcinB, we measured
the growth curves of E. coli with each of them. The growth of E. coli with
free biotin or with PBS, as a negative control, was also compared. The
growth curves of E. coli with biotinylated LfcinB or LfcinB exhibit the
same antibacterial activity. E. coli with biotin is similar to the negative
control.
doi:10.1371/journal.pone.0028197.g002
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complex is stimulated with polarized light. The light emits in the
same polarized plane, and the complex is maintained in the same
plane of polarization, causing an increase in the degree of
polarization [22–24]. The amount of molecules binding to a
fluorophore influences the degree of polarization [24]. In this
study, LfcinB was labeled with DyLight
TM 549 as a reference
value. Once the protein bound to LfcinB, like a fluorophore binds
to a large molecule, a high degree of polarization is expected. As
shown in Figure 5A–5D, HyaF, NrdF, MetL and CyaA have
higher polarization than the negative control (Bovine Serum
Albumin, BSA). The degree of polarization remained constant
with increasing concentrations of BSA but increased with
increasing concentrations of these 4 proteins. These results
confirm that LfcinB binds to these 4 representative proteins.
Similarly, 12 more proteins (RecC, YnhE, YdaU, YcaO, YqiA,
YjbM, YhaN, Ppc, GldA, Adi, MalP and NrdD) were confirmed
to bind to LfcinB (data not shown). Therefore, we further analyzed
the functions of these 16 proteins. Interestingly, 3 of these proteins
(NrdD, NrdF and CyaA) are involved in purine metabolism, and
LfcinB had been shown to inhibit DNA and RNA synthesis [7].
One possible explanation of this earlier finding is that LfcinB may
attack NrdF, NrdD and CyaA to inhibit DNA synthesis.
Functional interaction analysis
We further exploited EcID to find the interacting proteins of
these 16 identified LfcinB targets to identify the proteins that are
indirectly influenced by LfcinB. The EcID integrates information
Figure 3. E. coli proteome chip assays with LfcinB. A. Schematic of chip assays. To select the proteins bound by LfcinB, E. coli proteome chips
were incubated with biotinylated LfcinB. DyLight
TM 649-labeled streptavidin was then probed with chips to identify the targets of LfcinB. DyLight
TM
549-labeled anti-His antibody was used to detect the relative amount of the proteins. Each protein was printed in duplicate on the chips. B. The chip
image. We showed the chip image in triplicate experiments and the enlarged blocks from each chip were on the left.
doi:10.1371/journal.pone.0028197.g003
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EcoCyc, KEGG, MINT and IntAct [25]. EcoCyc supplies E. coli
metabolic pathways, protein complexes and regulatory informa-
tion; KEGG, MINT and IntAct provide metabolic pathways and
protein interaction information. Moreover, the EcID also contains
information on protein complexes from high-throughput pull-
down assays conducted in E. coli and attaches the literature to
support potential functional interactions. In this study, we only
selected interactions through the experimental mode and not the
prediction mode. We also chose the interacting proteins that have
functional interactions with at least 5 out of the 16 target proteins
identified in the FP assays. We proposed that more target proteins
of LfcinB interacting with the same protein may have a larger
influence on that protein; conversely, a protein interacting with
fewer target proteins of LfcinB is less influenced by LfcinB.
Therefore, we chose the interacting proteins that have functional
interactions with at least 30 percent of the target proteins (5 out of
16) as a criterion in this study. As shown in Figure 6, 7 targets of
LfcinB (MalP, Ppc, CyaA, NrdF, NrdD, Adi and HyaF) were
‘‘hubs’’ that connected many interacting proteins in the network.
Thus, the attack of these hubs by LfcinB may have a large
influence on E. coli. From this analysis, 21 interacting proteins
were found to have interactions with at least 5 out of the 16 targets
and are thus likely to be indirectly influenced by an LfcinB attack.
We further analyzed these 21 interacting proteins. Interestingly,
Table S1 shows that 13 out of the 21 proteins are enriched in the
TCA cycle. The TCA cycle is a series of enzyme-catalyzed
reactions of central importance in living cells that converts
carbohydrates, fats and proteins into an available form of energy.
These results suggest that LfcinB may indirectly influence energy
metabolism in E. coli.
Knockout assays
Knockout strains were designed without a specific gene
according to the results of the FP assays. If the lost protein was
a target of LfcinB, the knockout strain may avoid the growth
inhibition caused by LfcinB and grow with the alternative or
redundant pathways. However, knockout assays have a limitation:
if the alternative or redundant pathways of the corresponding
target protein of the knockout strain are also attacked by LfcinB,
the strain will not avoid the growth inhibition caused by LfcinB.
Thus, we cannot conclude that the protein is not the target of
LfcinB if no growth inhibition is observed in the knockout strain.
Knockout assays only provide additional positive confirmations.
The effect of LfcinB on the growth of the 16 E. coli knockout
strains and their isogenic parent strain were investigated.
Interestingly, in the initial part (0–1.5 h) of the growth curves,
both the isogenic parent strain and the knockout strains grown
with LfcinB had higher growth curves than the strains grown
without LfcinB (Figure 7). It is possible that LfcinB served as
nutrient for bacteria in the beginning of the assay. Similarly,
Ulvatne et al. [7] observed that DNA synthesis was increased at the
Table 1. The top 153 proteins.
Rank 1–26 Rank 27–52 Rank 53–78 Rank 79–104 Rank 105–130 Rank 131–153
HhoB RplN ArgH PurC YqcA PtsA
671#8 YhiW RhaR AgaY YrhA YbbN
YhbN YegJ RpsB YibA YjdI XerB
YdaU YtfI AmiA YbeV YciW CaiA
BasR YciT HyaF AceK AtpH Sun
YifN YeeL MdoG RhaD YjeJ SoxR
IlvG YbaQ CadA YffC HolC YjhI
RplE YjdK YnhE AdiY PaaG YjaE
RplW DinG YggF NrdF NrdD YbcQ
YihI YihS AroD HofH YdeY WcaL
GldA CyaA YgfJ YhgA PtsA RffH
YbaO YheH HyaE PerM EnvR YhhI
YjgL GloA MetL YfbR YbgN Rob
SoxS YjbM IlvL YcgW YpdH YobG
DnaT SfmH YibB YjiV YhiF HisA
YdiT YgiG RcsB YibN YbgE YbeY
RfaS YhdG HolB YqiA ThiF YdhS
CreB YbcX GidB YhaJ FlgC YqhC
InfC DsbG RecC HemK YjeG YdaW
RfaD YcgK RfaZ Adi YbeQ YnjI
YcaO HemC Hha YchA CbpA YfbO
YdcC YrfI YhaN GlyQ YcdN YfiQ
YbaE DsbC FimZ GlpK YjiL YjfW
Smg GlgS Ppc YjeS YfeF
SrmB YlbE YhjH YhjC MalP
DedD YehS YijC YceC YefE
doi:10.1371/journal.pone.0028197.t001
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of the growth curves, the slopes of both the isogenic parent strain
and the knockout strains with LfcinB were lower than the slopes
of the strains without LfcinB, indicating that LfcinB started to
affect the growth of cells at this time. At the end (after 4 h) of the
growth curves, 1 of the 16 knockout strains (Dppc) showed similar
OD595 value with and without LfcinB (Figure 7A). However, the
growth curves of the isogenic parent strain (Figure 7B) as well as
the other 15 proteins (ynhE is shown as a representative strain in
Figure 7C) with and without LfcinB were obviously different
(p=0.02). It appears that LfcinB inhibited the growth of the
isogenic parent strain and 15 proteins; however, the growth
curves of Dppc were not different with or without LfcinB
(p=0.73). These results indicate that the ppc knockout strain
successfully protected itself from the LfcinB attack. Moreover, the
alternative or redundant pathways of ppc were not influenced by
LfcinB; thus, the ppc knockout strain avoided the LfcinB attack.
For the other 15 knockout strains, the growth was inhibited by
LfcinB because LfcinB may attack the targets and their
alternative or redundant pathways simultaneously. Overall, the
confidence of Ppc as an LfcinB target was increased through
these knockout assays.
Pyruvate assays
Ppc, phosphoenolpyruvate carboxylase, converts bicarbonate
and phosphoenolpyruvate to oxaloacetate. In pyruvate metabo-
lism, phosphoenolpyruvate is converted to either pyruvate or
oxaloacetate (Figure S2). When Ppc is inactivated, phosphoenol-
pyruvate cannot be converted to oxaloacetate, only to pyruvate,
which causes an increase in pyruvate concentration. Several
studies have reported that the complete knockout of the ppc gene
can lead to an increase in the concentration of pyruvate [26,27],
and pyruvate accumulation could inhibit growth [28]. Therefore,
one of the mechanisms of LfcinB inhibition of E. coli growth may
be associated with pyruvate accumulation.
Pyruvate is the simplest alpha-keto organic acid. It is the
product of glycolysis and is a key molecule in the network of
metabolic pathways that can be converted into a variety of
Figure 4. GO analyses of the top 153 identified proteins. GO provides each defined term representing gene product properties. Herein, we
showed 2 domains in the figure: A. Biological process, B. Molecular function. A p-value cut-off of 0.05 is used for analyses. The size of the term
symbolizes the total gene membership; the size increases with an increasing number of genes. The color depth of each term illustrates the degree of
enrichment; the color increases with a decreasing p-value. These identified proteins in the chip assays are primarily associated with cellular
macromolecular metabolic processes, macromolecular metabolic processes and primary metabolic processes.
doi:10.1371/journal.pone.0028197.g004
Figure 5. Validation of the interactions between LfcinB and proteins using fluorescence polarization assays. FP assays provide a
homogeneous-based environment for a binding test, eliminating immobilization and separation procedures. We used FP assays to conduct screening
for protein-peptide interactions. The rotation of fluorescently labeled LfcinB (a small molecule) is faster and hence causes the emitted light to be
depolarized. When LfcinB binds to the target proteins, the molecular weight becomes larger and makes the rotation slow. Thus, the degree of
polarization becomes higher. In FP assays, the polarization values of the tested proteins were compared with BSA (negative control). The blue circle is
a sample and the orange square is BSA. Sixteen out of the 153 proteins have apparent differences from BSA. A. HyaF, B. NrdF, C. MetL and D. CyaA
are representative FP results.
doi:10.1371/journal.pone.0028197.g005
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or ethanol. It is involved in several key metabolic processes. To
prove that one of the mechanisms of LfcinB action is related to
pyruvate metabolism, a pyruvate assay was used to detect the
amount of pyruvate in E. coli with or without LfcinB. A minimal
medium with a sole carbon source, glucose, was used in the
pyruvate assays to ensure that pyruvate was generated only via
glycolysis. Based on the function of Ppc, we hypothesized that the
LfcinB-attacked E. coli possibly lost a route of converting
phosphoenolpyruvate to oxaloacetate and therefore had an
accumulation of pyruvate. In Table 2, the OD595 and OD570
values represent the amount of E. coli and pyruvate, respectively.
We observed that the amount of E. coli with or without LfcinB as
equivalent in the initial stage. After 9 h of incubation, the amount
(OD595)o fE. coli with LfcinB was lower than the level of E. coli
without LfcinB, due to the inhibition of LfcinB; however, the
pyruvate (OD570) level in E. coli with LfcinB was higher than the
level in E. coli without LfcinB. Thus, these results indicate that E.
coli with LfcinB has abnormal pyruvate accumulation and this is
one reason for the inhibition of E. coli growth.
Discussion
A rapid, reliable and high-throughput tool to study
antimicrobial peptides
The proteome chip is a useful technology that has been applied
to various types of research [10,11,15,16]. In this study, we used
this tool to study the interactions between the defense systems of
multi-cellular organisms and bacteria. Understanding the mech-
anisms of how these natural antimicrobial peptides targeted and
disrupted the complex regulatory network within the cells may
provide clues for the development of new strategies and
compounds to against bacteria effectively. By using proteome
chips, we can easily obtain proteins that were possible targets of
LfcinB. We then conducted bioinformatic analyses (ProCAT and
GO analyses) to process the chip results. ProCAT was used to
Figure 6. The functional interaction network of the 16 target proteins identified from the fluorescence polarization assays. Each
square shape represents the target proteins identified from the FP assays, and round shapes represent the interacting proteins. The EcID was used to
find the interacting proteins of these 16 targets. Here, we showed only the proteins that interact with at least 5 targets, and 21 interacting proteins
were identified. The thicker line symbolizes that more databases show that they have an interaction between 2 proteins. Seven out of the 16 target
proteins, NrdD, CyaA, MalP, Adi, NrdF, Ppc and HyaF, have more interactions and are considered to be hubs.
doi:10.1371/journal.pone.0028197.g006
Intracellular Targets of Lactoferricin B
PLoS ONE | www.plosone.org 7 December 2011 | Volume 6 | Issue 12 | e28197normalize the chip signals and obtain a reliable protein list and
GO analyses were used to classify the protein list.
Limitations of knockout assays
To validate the chip-identified proteins that bind to LfcinB, FP
assays were used to study the interactions between proteins and
LfcinB. FP assays have been used to identify the inhibitors of the
p53-DM2 protein-protein interaction [29]. Through FP assays, we
obtained a list of 16 proteins that bind to LfcinB. We used an
additional validation method (knockout assays) to identify these
select proteins and observe the physiological condition of the
bacteria. With this assay, we identified only 1 target protein of
LfcinB, Ppc. However, many proteins exhibiting specific dose-
dependent polarization values in the FP assays, such as NrdF
(ribonucleoside-diphosphate reductase 2, b subunit dimer), were
not confirmed to be associated with LfcinB activity in the knockout
assays. One possible explanation for this disparity is gene
redundancy, a limitation of knockout assays. When several genes
perform the same function and have similar structures, they may
be attacked simultaneously by LfcinB. In this case, a single gene
knockout could not avoid the LfcinB attack; therefore, growth was
still inhibited by LfcinB. For example, NrdF has a similar function
as NrdB [30,31]; they both convert ribonucleotide to deoxynu-
cleotide, providing the precursors for DNA synthesis and repair
[32,33]. When NrdF is inactive, NrdB action can replace the
function of NrdF. NrdF and NrdB also have similar structures
[30]. Our chip results showed that both NrdF and NrdB were
targets of LfcinB. Although NrdB was not in the top 153 proteins,
it still had a strong binding affinity with LfcinB in chip assays. The
growth curve of the nrdF knockout mutant with LfcinB was
significant inhibited compared to the growth curve of the nrdF
knockout mutant without LfcinB, indicating that the nrdF
knockout strain cannot avoid the LfcinB attack because nrdB
was also attacked by LfcinB. Although NrdF was not validated in
Figure 7. Comparison of the growth inhibition between knockout strains and the isogenic parent strain using knockout assays. We
compared the effects of LfcinB on the growth of 16 E. coli knockout strains and the isogenic parent strain to examine which gene can escape from the
effects of LfcinB. We used PBS (LfcinB dissolving buffer) as the negative control. A. Dppc with or without LfcinB have similar growth curves (p.0.05).
B. The isogenic parent strain has a significant difference (p,0.05) between treatment with or without LfcinB. C. DynhE, representing the other 15
knockout strains (p,0.05), is similar to the isogenic parent strain. These results indicate that Dppc avoided the LfcinB attack.
doi:10.1371/journal.pone.0028197.g007
Table 2. Pyruvate assay validation.
E. coli E. coli + LfcinB
Initial value of OD595 0.05760.002 0.05860.001
Value of OD595 after 9 h incubation 0.32560.011 0.26760.011
Value of pyruvate (OD570) after 9 h
incubation
1.97660.084 2.52660.338
Note. We used pyruvate assay kit to detect the pyruvate levels of E. coli with or
without LfcinB treatment. The E. coli with and without LfcinB had equivalent
amounts in the initial stage. After an incubational time of 9 h, we found that E.
coli with LfcinB had more pyruvate than the E. coli without LfcinB, even though
it had lower amount of E. coli.
doi:10.1371/journal.pone.0028197.t002
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the limitations of knockout assays.
The EcID analysis
The EcID was downloaded and processed to uncover proteins
that were highly related to the targets. According to the network,
7 out of the 16 FP identified proteins were hubs. These hubs have
different functions, including pyruvate metabolism, purine/
pyrimidine metabolism, amino acid metabolism and carbohy-
drate metabolism. Three out of the 7 hubs, NrdF, NrdD and
CyaA, were associated with purine metabolism. NrdF and NrdD
belong to the ribonucleotide reductase family and supply the
materials for DNA synthesis and repair. CyaA is an adenylate
cyclase that catalyzes the conversion of ATP to cyclic-AMP.
Although they are all involved in purine metabolism, NrdF and
NrdD have a more direct relationship with DNA synthesis than
CyaA. As mentioned previously, the synthesis of DNA and RNA
is inhibited by LfcinB [7], which may be due to an LfcinB attack
of NrdF and NrdD.
We analyzed not only the hubs but also interacting proteins.
The majority of the proteins that interact with at least 5 out of the
16 identified proteins in the FP assays (SdhD, AcnA, AcnB, SdhA,
SdhB, LpdA, SucA, SucD, SucC, FumB, SdhC, SucB and GltA)
were involved in the TCA cycle (13 out of 21); a minority of these
proteins participated in purine/pyrimidine metabolism (PolA,
PykF, GuaA and Hpt) or pyruvate metabolism (PykF, PflB and
LpdA). Of the proteins that interact with at least 6 out of the 16
identified proteins in the FP assays, 6 interacting proteins were
retained in the network. Four out of these 6 interacting proteins
(LpdA, SucD, FumB and SucC) were related to the TCA cycle. Of
the proteins that interact with at least 7 out of the 16 identified
proteins in the FP assays, PflB was the only interacting protein in
the network. PflB is an enzyme that catalyzes the conversion of
pyruvate into formate and acetyl-CoA (Figure S2). When PflB was
inactive, it stopped the normal pyruvate conversion, which may
lead to an increase in pyruvate levels [34]. Therefore, these data
may also explain the pyruvate accumulation seen when E. coli is
under the LfcinB attack.
LfcinB and pyruvate accumulation
Ppc is one of the direct targets of LfcinB, as seen in the results
from the chip assays, FP assays and knockout assays. However,
PflB is an indirect target of LfcinB, according to the functional
interaction analysis (EcID). PflB was the only protein that interacts
with at least 7 out of the 16 identified proteins in the FP assays,
suggesting that once the directly targeted proteins were attacked
by LfcinB, PflB may be inactive because it was associated with
those proteins. Phosphoenolpyruvate, the upstream metabolite of
pyruvate, has only two downstream pathways. The first pathway
forms oxaloacetate through the catalysis of Ppc, and the other
pathway forms pyruvate. PflB further converts pyruvate to formate
and acetyl-CoA (Figure S2). Therefore, when Ppc was inactive, it
stopped phosphoenolpyruvate from being converted to oxaloac-
etate and only allowed the conversion to pyruvate; when PflB was
inactive, it stopped pyruvate from being converted to formate.
Although their mechanisms are different, the inactivation of Ppc
and PflB both cause pyruvate accumulation.
Conclusion
This study used high-throughput E. coli proteome chips to find
potential intracellular mechanisms of action for antimicrobial
peptides. Chip and FP assay results indicate that LfcinB has
multiple targets. Knockout and pyruvate assays showed that one of
the mechanisms of LfcinB action is related to pyruvate
accumulation. These findings suggest that the proteome chip is a
useful and novel tool for studying the intracellular targets and
mechanisms of antimicrobial peptides. We expect a wide
application of this approach for studying the interactions of other
antimicrobial peptides and antibacterial agents.
Materials and Methods
Fabrication of an E. coli proteome chip
To fabricate the proteome chips, E. coli K-12 proteins were
expressed and purified in a high-throughput fashion. The
procedure was modified from Chen et al. [9]. Briefly, E. coli
protein expression clones fused with a 66-His tag, provided by Dr.
Mori [35], were first incubated with glass beads (Biospec Products
Inc.) in 26LB medium containing 30 mg/ml chloramphenicol in
96 DeepWell
TM plates (Nunc) at 37uC overnight. The overnight
cultures were then diluted with 26 LB that contains 30 mg/ml
chloramphenicol to the OD595 value of 0.1. When the cells grew to
an OD595 value of 0.7–0.9, 500 mM of isopropyl b-D-thiogalacto-
side (IPTG) was added to induce protein expression at 37uC for
,3.5 h. The cultures were then harvested by centrifugation at
3220 g for 5 min at 4uC, and the pellets were stored at 280uC
before purification.
To purify the proteins, the frozen cell pellets were thawed on
ice and resuspended at 4uCi n4 0ml of lysis buffer, consisting of
50 mM NaH2PO4, 300 mM NaCl, 30 mM imidazole, CelLyticB
(Sigma-Aldrich), 1 mg/ml lysozyme, 50 units/ml benzonase,
proteinase inhibitor cocktail (Sigma-Aldrich), 1 mM phenyl-
methanesulfonyl fluoride (PMSF) and Ni-NTA Superflow resins
(Qiagen). After a 2.5 h incubation on a plate shaker at 4uC, the
mixtures were transferred into 96-well filter plates (Nunc) and
washed with wash buffer I (50 mM NaH2PO4, 300 mM NaCl,
20% glycerol, 20 mM imidazole and 0.1% Tween 20, pH 8) 5
times and wash buffer II (50 mM NaH2PO4, 150 mM NaCl,
30% glycerol, 30 mM imidazole and 0.1% Tween 20, pH 8) 5
times. Finally, the proteins were eluted with elution buffer
(50 mM NaH2PO4, 150 mM NaCl, 30% glycerol, 300 mM
imidazole and 0.1% Tween 20, pH 7.5). When the purified
proteins were prepared, they were printed in duplicate along with
BSA, serum proteins, antibodies and histone as negative controls
or landmarks on Fullmoon slides by ChipWriter Pro (Bio-Rad)
with 48 pins in a 4uC cold room. After printing, the chips were
immobilization at 4uC for at least 8 h and then stored at 280uC
before utilization.
The influence of biotinylated LfcinB, LfcinB and biotin on
E. coli growth
The E. coli K-12 MG1655 strain was first inoculated into LB
medium and incubated at 37uC with shaking for 16 h. After
incubation, the culture was diluted to approximately 10
7 CFU/ml
using LB medium. Then, 22.4 mM of N-terminal biotinylated
LfcinB (Kelowna Inc.), LfcinB (Kelowna Inc.) or biotin (Thermo)
were individually added to the diluted cultures in a 96-well plate.
PBS was used as a negative control. Finally, each compound or
PBS with E. coli was incubated at 37uC with shaking and the
growth curves were observed by measuring the OD595 value every
20 min for 7 h 20 min in a microplate reader (Synergy 2,
BioTekH).
E. coli proteome chip assays with LfcinB
The chip was first blocked with 1% BSA. Ten nM of N-terminal
biotinylated LfcinB with 1% BSA was probed with the chip in a
hybridization chamber on a 3D shaker at room temperature for
1 h. The chip was then washed 3 times with Tris-buffered saline-
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TM 549-labeled anti-His antibody
(abcamH) and DyLight
TM 649-labeled streptavidin (Thermo) were
then probed on the chip at room temperature for 30 min. Finally,
the chip was washed 4 times with TBS-T in an orbital shaker. The
chip was dried by centrifugation at 201 g and then scanned with a
microarray scanner (Axon GenePixH 4000B) after being rinsed
with distilled water.
Bioinformatics analyses of the chip assay results
For image processing of chip assay results, Genepix Pro 6.0
was used to align the protein spot of each individual protein and
then all aligned protein image signals were exported as a text file.
The text file was analyzed by ProCAT [17], a signal
normalization method. The relative ability of LfcinB to bind to
each protein was estimated by the ratio of the fluorescence
intensity of LfcinB to the fluorescence intensity of an anti-His
antibody after the normalization. All the bioinformatics analyses
were performed by Perl 5.0.
For the gene enrichment analysis of the identified proteins, the
BiNGO software, a plug-in for Cytoscape, was used [19]. Because
the gene annotation file of E. coli was not included in the default
settings, the annotation file was downloaded from the GO Website
(http://www.geneontology.org/) and imported while the GO was
in progress. A p-value cut-off of 0.05 was used for the analyses.
Fluorescence polarization assays
Before the assays, LfcinB was labeled with DyLight
TM 549 and
tested proteins were quantified with a PierceH bicinchoninic acid
(BCA
TM) protein assay (Thermo). To label the LfcinB, DyLight
TM
549-NHS ester and LfcinB (68:1, mole/mole) were mixed in PBS
at room temperature for 1 h, a D-Salt
TM polyacrylamide desalting
column (Thermo) was used to remove excess dye and the labeling
efficiency of the eluted solution was calculated.
After blocking the 96-well black plate with 1% BSA at room
temperature for 1 h, a two-fold serial dilution of proteins from
0.4 mM to 0.025 mM was prepared in the assay buffer (PBS,
0.005% BSA and 0.01% Triton X-100) and added to the plate.
Serially diluted BSA (0.4 mM, 0.2 mM, 0.1 mM and 0.05 mM) was
also used as a negative control. After calculating the labeling
efficiency, 100 nM of fluorescence-labeled LfcinB, used as a
tracer, was incubated with protein or BSA at room temperature
for 1 h. The degree of polarization of each well was detected by a
microplate reader, using an excitation wavelength of 540 nm and
an emission wavelength of 590 nm with a dichroic mirror of
570 nm.
Functional interaction analysis
The EcID was used for functional interaction network analyses
of the identified proteins from the FP assays. Briefly, the entity and
pair files were downloaded from EcID. For data pre-processing,
the pair file was filtered by removing the protein-protein
interaction pairs that were based on prediction mode, such as
phylogenetic profiles or gene neighborhoods. After pre-processing,
the identified proteins were mapped to their EcID IDs and the pair
file was scanned to recognize which proteins will interact with the
identified proteins. Cytoscape [36] was used to generate the
functional protein interaction network, and it visualized the
identified proteins with their interacting partners. All of the
intermediate procedures were completed by Perl 5.0.
Knockout assays
The E. coli K-12 BW25113 (isogenic parent) strain and the 16
knockout strains were obtained from the E. coli Genetic Resources
at the Coli Genetic Stock Center (CGSC) at Yale University. The
strains were inoculated into LB medium, and incubated at 37uC
with shaking. After 16 h of incubation, the cultures were diluted to
approximately 10
7 CFU/ml with LB medium. Thirty-two mMo f
LfcinB were then added to the cultures in a 96-well plate. PBS was
used as a negative control. Cultures with LfcinB or PBS were then
incubated at 37uC with shaking in a microplate reader and the
growth was observed by measuring the OD595 value every 20 min
for 7 h 20 min.
Pyruvate assays
To confirm one of the mechanisms of LfcinB action in pyruvate
metabolism, a minimal medium was chosen; because general LB
medium contains many carbon sources, including sugars, alcohols
and organic acids, this minimal medium allowed glucose to be the
sole carbon source in the pyruvate assays. Minimal medium
consisted of 6 g/l NaH2PO4, 3 g/l K2HPO4, 0.5 g/l NaCl,
0.12 g/l MgSO4, 1 g/l NH4Cl, 0.01 g/l CaCl2 and 5 g/l glucose.
A 0.22 mm filter (MillexHGS, Millipore) was used to filter the
minimal medium. E. coli MG1655 was first inoculated into the
minimal medium and incubated at 37uC for 16 h with shaking as a
preculture. The preculture was diluted 100-fold with the minimal
medium in 96-well plate, and 32 mM of LfcinB were added. The
mixture was incubated with shaking in a microplate reader at
37uC, and the absorbance was measured after 9 h. Finally, the
mixture was harvested by centrifugation at 3452 g for 5 min at
4uC, and each supernatant was removed. The pellets were then
stored at 280uC.
To extract the pyruvate in E. coli, hot water extraction was used,
a procedure adapted from Canelas et al. [37]. Boiling water was
poured into the pellet and it was immediately vortexed. The
mixture was then placed in a water bath at 95–100uC for 15 min
and cooled on ice. When the extraction was complete, a pyruvate
assay kit (BioVision, K609-100) was used to detect the pyruvate
level in the extracts. A reaction mixture, containing a pyruvate
assay buffer, a pyruvate probe and an enzyme mix, was added to
each pyruvate extract. The mixtures were then incubated for
30 min at room temperature to allow pyruvate oxidization by
pyruvate oxidase and the solution to change color to red. Finally,
the OD570 of the mixtures was measured by a microplate reader to
detect the color intensity.
Supporting Information
Figure S1 The quality of an E. coli proteome chip. The
chip image showed the quality of a protein chip by probing
DyLight
TM 549-labeled anti-His antibody. The majority of the
proteins show strong signals.
(TIF)
Figure S2 Partial pyruvate pathway. Phosphoenolpyruvate
and bicarbonate are converted to oxaloacetate by Ppc. Phospho-
enolpyruvate is converted to pyruvate by PykFA. Pyruvate is
converted to formate and acetyl-CoA by PflB.
(TIF)
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